RT Journal Article
SR Electronic
T1 690 High safety and efficacy of CRISPR-Based non-viral PD1 locus specific Integrated Anti-CD19 CAR-T cells (BRL-201) in treating relapsed or refractory non-Hodgkin’s lymphoma: first-in-human phase I study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A782
OP A782
DO 10.1136/jitc-2023-SITC2023.0690
VO 11
IS Suppl 1
A1 Zheng, Biao
A1 Hu, YongXian
A1 Zhang, Jiqin
A1 Zhang, Mingming
A1 Li, Wei
A1 Wu, Wenjun
A1 Cui, Jiazhen
A1 Wei, Guoqing
A1 Du, Bing
A1 Liu, Mingyao
A1 Huang, He
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A782.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.